Virtual Group Resilient Living for Advanced Cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-arm study conducted virtually at Mayo Clinic to test the feasibility and potential benefits of a 7-week Virtual Group Resilient Living Program. Participants learn stress-management and resilience techniques such as mindfulness, positive reframing, gratitude, compassion, acceptance, meaning, and forgiveness in a group setting, with the aim of improving anxiety, stress, quality of life, coping, and fatigue. The study also collects survey data to assess feasibility and preliminary effectiveness, and is designed for minimal risk. Eligibility requires adults with stage III/IV cancer, baseline distress, English fluency, internet access, and ability to participate in online sessions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* English fluency
* Diagnosis of advanced (stage III/IV) malignancy
* Baseline distress score ≥ 4/10. Patients can answer questions orally rather than complete worksheet, if applicable
* Life expectancy of ≥ 6 months
* Provide informed consent
* Ability to complete questionnaire(s) by themselves or with assistance
* Has a reliable internet connection
* Has the ability to utilize technology to watch online modules, \& participate in virtual sessions

Exclusion Criteria:

* As determined through self-report, those diagnosed with a history of a psychotic episode ≤ 5 years
* All psychological co-morbidities such as a history of untreated schizophrenia, \& bipolar disease
* A diagnosis of severe cognitive impairment

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Deirdre R. Pachman, MD — Mayo Clinic
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Concise coaching to guide decisions for advanced cancer patients considering palliative procedures

  A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.

  Recruiting Singapore General Hospital · Singapore · NCT07789093

• Primary Palliative Care: A Feasibility Project for Family Health Units

  This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.

  Recruiting University of Coimbra · Coimbra and 1 other locations · NCT07737899

• IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy

  This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07648160

• Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain

  A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07636382

• UI-102 in advanced cancers (phase 1/2) first-in-human

  A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.

  Recruiting at 3 sites Phase 1/2 United Immunity, co., Ltd. · Dallas, Texas and 2 other locations · NCT07605962

• Givastomig with nivolumab and chemotherapy for CLDN18.2-positive metastatic stomach or gastroesophageal junction cancer

  This study will see if adding givastomig to nivolumab plus standard chemotherapy helps adults with CLDN18.2- and PD-L1-positive metastatic stomach or gastroesophageal junction cancer live longer without their disease getting worse.

  Recruiting at 5 sites Phase 2 I-Mab Biopharma US Limited · Goodyear, Arizona and 5 other locations · NCT07432295

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.